Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3245801rdf:typepubmed:Citationlld:pubmed
pubmed-article:3245801lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:3245801lifeskim:mentionsumls-concept:C0012634lld:lifeskim
pubmed-article:3245801lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:3245801lifeskim:mentionsumls-concept:C0002556lld:lifeskim
pubmed-article:3245801lifeskim:mentionsumls-concept:C0442388lld:lifeskim
pubmed-article:3245801pubmed:issue5lld:pubmed
pubmed-article:3245801pubmed:dateCreated1989-5-26lld:pubmed
pubmed-article:3245801pubmed:abstractTextTranstympanic administration of gentamicin was used to treat patients with unilateral Menière's disease and was stopped at the first signs of damage to cochlear and/or vestibular function. Twenty-eight patients were treated between 1974 and 1981 and 34 patients were managed between 1981 and 1987. In the two groups of patients, objective vertigo disappeared in 85%, hearing improved in 26%, aural fullness disappeared in 78%, while tinnitus ceased altogether in 51% and became less intense in 24%. Our findings show that this kind of treatment can be used after unsuccessful medical therapy and prior to any labyrinthine or endolymphatic sac surgery.lld:pubmed
pubmed-article:3245801pubmed:languageenglld:pubmed
pubmed-article:3245801pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3245801pubmed:citationSubsetIMlld:pubmed
pubmed-article:3245801pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3245801pubmed:statusMEDLINElld:pubmed
pubmed-article:3245801pubmed:issn0302-9530lld:pubmed
pubmed-article:3245801pubmed:authorpubmed-author:SalePPlld:pubmed
pubmed-article:3245801pubmed:issnTypePrintlld:pubmed
pubmed-article:3245801pubmed:volume245lld:pubmed
pubmed-article:3245801pubmed:ownerNLMlld:pubmed
pubmed-article:3245801pubmed:authorsCompleteYlld:pubmed
pubmed-article:3245801pubmed:pagination293-6lld:pubmed
pubmed-article:3245801pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:3245801pubmed:meshHeadingpubmed-meshheading:3245801-...lld:pubmed
pubmed-article:3245801pubmed:meshHeadingpubmed-meshheading:3245801-...lld:pubmed
pubmed-article:3245801pubmed:meshHeadingpubmed-meshheading:3245801-...lld:pubmed
pubmed-article:3245801pubmed:meshHeadingpubmed-meshheading:3245801-...lld:pubmed
pubmed-article:3245801pubmed:meshHeadingpubmed-meshheading:3245801-...lld:pubmed
pubmed-article:3245801pubmed:year1988lld:pubmed
pubmed-article:3245801pubmed:articleTitleTranstympanic administration of aminoglycosides in patients with Menière's disease.lld:pubmed
pubmed-article:3245801pubmed:affiliationENT Department, Hospital of Mestre, Venice, Italy.lld:pubmed
pubmed-article:3245801pubmed:publicationTypeJournal Articlelld:pubmed